Dr. Douglas Evans | Surgery | Best Researcher Award

Dr. Douglas Evans | Surgery | Best Researcher Award

Dr. Douglas Evans, Medical College of Wisconsin, United States

Dr. Douglas B. Evans is a distinguished leader in surgical oncology and currently serves as Chair of the Department of Surgery at the Medical College of Wisconsin. His medical expertise focuses on pancreatic cancer and complex surgical oncology, where he has made significant contributions through his leadership and research. He is highly respected for his extensive work at prestigious institutions, including the University of Texas MD Anderson Cancer Center, where he previously held a tenured professorship. Dr. Evans’ commitment to advancing cancer research and improving patient care has earned him recognition nationally and internationally. He has served on multiple national advisory boards and contributed to various scientific committees. Dr. Evans’ work continues to impact the fields of surgery and oncology, enhancing the understanding and treatment of pancreatic cancer.

Professional Profile

scopus

google scholar

Summary of Suitability for the Research for Best Researcher Award

Dr. Douglas B. Evans, with his extensive background in surgical oncology and a distinguished career, is highly suited for the Research for Best Researcher Award. His leadership as Chair of the Department of Surgery at the Medical College of Wisconsin since 2009 demonstrates his commitment to advancing surgical practices and medical education. His impressive list of academic and clinical roles, including his tenure as a professor at the University of Texas M. D. Anderson Cancer Center, highlights his sustained contributions to the field of cancer research, particularly in pancreatic and thyroid cancers.

🎓 Education 

Dr. Douglas B. Evans received his foundational education at Oliver Ames High School in North Easton, Massachusetts. He then attended Bates College in Lewiston, Maine, where he earned his Bachelor of Science degree. His medical journey continued at Boston University School of Medicine, where he obtained his M.D. Following this, Dr. Evans pursued postgraduate training in surgery at Dartmouth-Hitchcock Medical Center, where he completed both his internship and residency in general surgery. His specialization in surgical oncology was honed during his fellowship at the University of Texas MD Anderson Cancer Center. This extensive academic background provided him with the expertise required to become a leading figure in the surgical treatment of pancreatic and gastrointestinal cancers. His licensures include multiple states such as Texas and Wisconsin, and he is board-certified by the American Board of Surgery, with recertifications reflecting his continued commitment to excellence in surgical practice.

💼  Experience 

Dr. Douglas B. Evans has an extensive career in surgical oncology, marked by significant leadership roles. He began as an Instructor in Surgery at Dartmouth Medical School and progressed to Teaching Associate at the University of Texas MD Anderson Cancer Center. At MD Anderson, Dr. Evans ascended from Assistant Professor to full Professor of Surgery, eventually securing the Hamill Foundation Distinguished Professorship in honor of Dr. Richard G. Martin, Sr. Since 2009, he has been the Chair of the Department of Surgery at the Medical College of Wisconsin, where he also holds the Ausman Family Foundation Chair. Dr. Evans’ career highlights include serving as Surgeon-in-Chief at Froedtert Hospital and contributing to numerous advisory boards and national committees. His experience and influence in academic surgery, particularly in pancreatic cancer research and treatment, have established him as a key figure in the surgical oncology field.

🏅 Awards and Honors 

Dr. Douglas B. Evans has received numerous awards and honors throughout his distinguished career in surgical oncology. Early recognition came with the Resident’s Publication Award in 1985, followed by the prestigious Thomas P. Almy Award in 1987. His dedication to teaching was acknowledged by multiple Outstanding Teacher Awards, notably in 1995 and 2003 at the University of Texas MD Anderson Cancer Center. In 1999, he was awarded the American College of Surgeons Traveling Fellowship. More recently, Dr. Evans was honored with the Andrew L. Warshaw Master Educator Award in 2014 from the Society for Surgery of the Alimentary Tract, as well as the Wisconsin Way Award in Medicine in 2018. In 2021, he was appointed to the Douglas B. Evans Chair for Surgical Research, a testament to his contributions to both clinical practice and academic surgery. In 2023, he received the Benjamin E. Mays Medal from Bates College, their highest alumni honor.

🌍 Research Focus

Dr. Douglas B. Evans’ research primarily focuses on the surgical treatment of pancreatic cancer and complex gastrointestinal cancers. His work has significantly advanced the understanding of pancreatic tumor biology and the development of surgical techniques to improve patient outcomes. He is particularly interested in translational research that bridges basic science discoveries and clinical applications. Dr. Evans has contributed to groundbreaking studies on the molecular mechanisms driving pancreatic cancer, enhancing the accuracy of surgical interventions and postoperative care. His research has been pivotal in the development of multi-disciplinary treatment approaches that combine surgery with chemotherapy and radiation therapy for pancreatic and other gastrointestinal cancers. As a renowned leader in his field, Dr. Evans has published extensively in high-impact medical journals, and his research efforts continue to shape the landscape of surgical oncology and improve the prognosis for cancer patients worldwide.

📖 Publication Top Notes

  • One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
    • Citation: 5547
  • Management of Thyroid Nodules Detected at US: Society of Radiologists in Ultrasound Consensus Conference Statement
    • Citation: 1921
  • Medullary thyroid cancer: management guidelines of the American Thyroid Association
    • Citation: 1712
  • Cancer-associated stromal fibroblasts promote pancreatic tumor progression
    • Citation: 1310
  • Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy
    • Citation: 1012

Prof. M. Rafael Salaberry | Linguistics | Best Researcher Award

Prof. M. Rafael Salaberry | Linguistics | Best Researcher Award

Prof. M. Rafael Salaberry, Rice university, United States

Dr. M. Rafael Salaberry is a distinguished scholar specializing in Spanish linguistics and second language acquisition. He is currently the Mary Gibbs Jones Professor of Humanities at Rice University, where he has been a faculty member since 2013. His academic journey began with a Ph.D. in Spanish Linguistics from Cornell University in 1997, following which he held prestigious positions at institutions like the University of Texas at Austin, Pennsylvania State University, and the University of Minnesota. Dr. Salaberry’s research interests focus on the intersection of language learning, cognitive studies, and applied linguistics. He has published extensively, with his works delving into tense and aspect in second language acquisition, interactional competence, and ethics in language testing. His contributions to language learning, diversity, and social justice in a post-COVID world continue to influence and shape linguistic studies globally.

Professional Profile

orcid

Summary of Suitability for the Award

M. Rafael Salaberry is highly suitable for the “Research for Best Researcher Award” due to his distinguished career in Spanish linguistics and second language acquisition. He has held prestigious academic positions, including his current role as the Mary Gibbs Jones Professor of Humanities at Rice University, and has an impressive academic background with a Ph.D. from Cornell University. His long-standing academic career, spanning over two decades, includes notable positions at leading institutions such as the University of Texas at Austin, Pennsylvania State University, and the University of Minnesota.

 🎓 Education 

Dr. M. Rafael Salaberry earned his Ph.D. in Spanish Linguistics with a minor in Cognitive Studies from Cornell University in 1997. His doctoral work centered around understanding tense and aspect in second language acquisition, a subject that has informed much of his later research. Prior to his Ph.D., he developed a strong academic foundation in Spanish linguistics and cognitive studies, which paved the way for his future roles as a professor and researcher in the field. His educational journey reflects a deep commitment to understanding the cognitive mechanisms involved in language learning, as well as the practical applications of linguistic theories. This academic background has enabled Dr. Salaberry to engage with complex linguistic phenomena and contribute to advancing the field of applied linguistics, particularly in Spanish language pedagogy and second language acquisition.

💼  Experience

Dr. Salaberry’s academic career spans over two decades, with prominent positions at top institutions. Since 2013, he has held the title of Mary Gibbs Jones Professor of Humanities at Rice University. Before joining Rice, he was a Professor of Spanish Linguistics at the University of Texas at Austin (2006-2013), and prior to that, an Assistant and Associate Professor at Rice University (2000-2006). His earlier appointments include roles as an Assistant Professor at Pennsylvania State University (1998-2000) and the University of Minnesota (1997-1998). Throughout his career, Dr. Salaberry has contributed significantly to language acquisition research and the development of new methodologies in linguistics. His teaching and mentoring have shaped countless students’ understanding of linguistics, particularly in the areas of Spanish language acquisition, applied linguistics, and cognitive studies, where he continues to be a leading voice.

🏅  Awards and Honors 

Dr. M. Rafael Salaberry has received numerous accolades for his contributions to linguistics and education. He was awarded the prestigious Mary Gibbs Jones Professorship of Humanities at Rice University in 2013, a recognition of his outstanding scholarship in the field. In addition to this honor, Dr. Salaberry has been acknowledged for his pioneering work in applied linguistics, particularly his research on second language acquisition. His publications, which span books, edited volumes, and journal articles, have received critical acclaim in the academic community. He has also been invited to contribute to several influential linguistic series and special issues, reflecting the high regard in which his work is held. Throughout his career, Dr. Salaberry’s dedication to ethical research and language diversity has garnered recognition and respect, solidifying his reputation as a leading scholar in his field.

 🌍 Research Focus 

Dr. M. Rafael Salaberry’s research focuses on second language acquisition, particularly the acquisition of tense and aspect in Spanish. His work explores how learners develop linguistic competence over time, with a strong emphasis on the role of cognitive mechanisms in language learning. He has also conducted extensive research on interactional competence, examining how language learners navigate and participate in social interactions. In recent years, his research has expanded to include ethical considerations in language testing and the role of language diversity in education, especially in a post-COVID context. Dr. Salaberry’s interdisciplinary approach combines insights from applied linguistics, cognitive studies, and social justice, making his work highly relevant in today’s globalized world. His research has been influential in shaping contemporary understandings of language learning processes, particularly for students learning Spanish as a second language.

📖 Publication Top Notes

  • Assessing speaking in context: Expanding the construct and the applications
  • Converging Agendas of Rationalist and Discursive Approaches for the Development of a Pedagogy of L2 Pragmatics
  • Expanding the Definition of Aspect in L2 Acquisition: Assessing Advanced Levels of Competence to Understand Aspectual Knowledge
  • Implementing the concept of ‘pedagogic mediation’ with the use of language corpora for the teaching of Portuguese as an L2 or L3
  • Influence of L1/L2 linguistic knowledge on the acquisition of L3 Spanish past tense morphology among L1 German speakers

David Monroy | Ocular Cancer | Best Researcher Award

David Monroy | Ocular Cancer | Best Researcher Award

  David Monroy, University of Miami, United States

David Monroy is a dedicated researcher with a strong background in neurocritical care and ophthalmology research. A graduate of Florida International University with a Bachelor of Science in Biological Sciences, David has developed significant expertise through his involvement in cutting-edge research projects. He has contributed to impactful studies at the University of Miami’s Neurology and Bascom Palmer Eye Institute, co-authoring numerous publications in esteemed journals. His focus on ocular surface tumors and brain injury has earned him recognition in the medical research community. David is passionate about scientific discovery and its real-world applications, aiming to bridge the gap between research and patient care. He is currently expanding his knowledge in traumatic brain injuries and their long-term outcomes through ongoing projects. His collaborative spirit and dedication to ethical research practices have positioned him as a promising young researcher in the medical field.

Professional Profile

  • orcid

    Education :

    David Monroy earned his Bachelor of Science in Biological Sciences from Florida International University (FIU) in 2020, where he followed a pre-medical track. As a student at FIU, David participated in various research programs, including the SEA-PHAGES program, where he discovered and analyzed novel bacteriophages. His educational journey was marked by an honors-level academic experience, which equipped him with the critical thinking and technical skills necessary for scientific research. Additionally, his time at FIU fostered a deep interest in neurobiology and medical sciences, which laid the groundwork for his subsequent research into neurocritical care and ophthalmology. Throughout his studies, David developed a comprehensive understanding of biological systems, disease mechanisms, and medical treatments, all while maintaining a high standard of academic achievement. His undergraduate experiences have significantly influenced his career trajectory in medical research.

    Experience :

    David Monroy’s research career includes notable roles such as Neurocritical Care Research Associate at the University of Miami, where he currently supports clinical studies in the neurosurgical intensive care unit. His work involves ensuring adherence to ethical protocols, communicating with patient families, and contributing to impactful studies on traumatic brain injury. Previously, David participated in ophthalmology research at the Bascom Palmer Eye Institute, focusing on ocular surface tumors and diagnostic techniques. He has authored multiple manuscripts and presented research findings at conferences, demonstrating his ability to communicate complex data effectively. During his time at Florida International University, he interned in a Parkinson’s disease research lab, where he gained experience in laboratory techniques and the study of neurodegenerative diseases. David’s career reflects a commitment to advancing medical knowledge through both clinical and basic science research, with a focus on improving patient care outcomes.

    Awards and Honors :

    David Monroy’s research and academic excellence have earned him several accolades. His work at the University of Miami’s Department of Neurology has been recognized for its contributions to understanding traumatic brain injuries, leading to multiple poster presentations at the prestigious Neurocritical Care Society conferences. Additionally, his studies on ocular surface tumors at the Bascom Palmer Eye Institute have resulted in peer-reviewed publications and presentations at the Association for Research in Vision and Ophthalmology (ARVO) conference. David’s commitment to advancing scientific knowledge has been rewarded with co-authorship on high-impact medical papers, underscoring his role in groundbreaking discoveries. While at Florida International University, he was part of the honors college, a testament to his academic dedication. His volunteer efforts, particularly with underserved communities, have also been recognized, reflecting his commitment to both research and service.

    Research Focus :

    David Monroy’s research is primarily focused on neurocritical care and ophthalmology, with an emphasis on traumatic brain injury and ocular surface tumors. In neurocritical care, his work has centered on understanding the cognitive and motor dissociation in brain injury patients, as well as examining the causes of traumatic brain injuries across different demographics. His research aims to improve long-term patient outcomes through innovative treatments and monitoring techniques. In ophthalmology, David has explored the infectious etiology of conjunctival tumors and developed diagnostic modalities for ocular surface squamous neoplasia. His research seeks to enhance early detection and improve therapeutic interventions for patients with ocular diseases. By collaborating with multidisciplinary teams, David continues to contribute to research that bridges the gap between laboratory findings and clinical applications, ensuring that his work has a tangible impact on patient care.

    Publication Top notes :

    • 📘 Alvarez OP., Monroy D., Thura S., et al. Infectious Etiology of Conjunctival Tumors. Expert Review of Ophthalmology, 2024.
    • 👁️ Monroy D., Venkateswaran N., Matthews JL., et al. Conjunctival keratoacanthoma: a clinical and histopathological case series. Canadian Journal of Ophthalmology, 2024.
    • 🔬 Monroy D., Serrano A., Galor A., & Karp CL. Medical treatments for ocular surface squamous neoplasia. Eye, 2023.
    • 💀 Monroy D., Garcia J., Zarate SD., et al. Displaced humeral pathological fracture secondary to intraosseous hemangioma. Radiology Case Reports, 2022.